/ 100
Nephrocare Health Services Limited (NEPHROPLUS) — Technical Setup
₹743.35 +1.12% Strong Uptrend Normal Volatility Strong bullish
Summary
Nephrocare Health Services Limited is in a strong uptrend on the daily chart. RSI(14) is 59.4, MACD is above its signal line, ADX reads 26 (trending). Volume in the latest session was 0.4× its 20-day average. Over three months it has outperformed the Nifty 50 by 9.7 percentage points. Nearest support is ₹725.00 and resistance ₹775.62. Its technical score is 81/100 (strong bullish).
🧮 How the 81/100 is built
Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.
- Close above 20-day EMA (2.76)3/3
- 20-day EMA above 50-day EMA3/3
- 50-day EMA above 200-day EMA0/3
- Close above 200-day SMA0/3
- SuperTrend (10,3) pointing up3/3
- ADX ≥ 20 with +DI above −DI (trend has strength) (25.88)3/3
- Weekly trend up (above a rising 30-week average)2/2
- RSI(14) in the bullish zone (55-70 best) (59.42)6/6
- MACD line above its signal line4/4
- MACD line above zero (15.42)3/3
- 12-day rate of change positive (7.31)3/3
- Stochastic %K above %D0/2
- Outperforming the Nifty 50 over 3 months (9.71)2/2
- On-balance volume rising over 20 sessions5/5
- Chaikin Money Flow (20) positive (0.04)3/5
- More volume on up days than down days (20 sessions) (1.88)5/5
- Close above 20-day VWAP (3.59)5/5
- Daily range (ATR%) contained — ≤2.5% scores full (3.44)4/6
- Price in the upper half of its Bollinger Bands (0.74)5/5
- Shallow drawdown from the 52-week high (-4.88)5/5
- Volatility contracting (20-day volatility below its 6-month median) (6.40)4/4
- Room to the next resistance (≥8% scores full) (4.34)3/5
- Support close below (a tight, definable stop) (2.47)5/5
- Broke above a 20-day high in the last 5 sessions0/5
- Within 5% of the 52-week high (-4.88)5/5
🧭 Regime: Strong Uptrend
Normal Volatility — Bollinger width is in the 42th percentile of the last six months.
Suits: Trend-following. Pullbacks to the 20-day EMA and breakouts tend to be bought in strong trends; mean-reversion shorts fight the tape.
Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.
Opens the AI Backtester with the Momentum Breakout rules for NEPHROPLUS — close at a 20-day high on 1.5× average volume, rsi above 55.
🕰️ Multi-timeframe
| Timeframe | Trend | RSI (14) | MACD hist. |
|---|---|---|---|
| Monthly | — | — | — |
| Weekly | ▲ Bullish | 67.19 | 2.36 |
| Daily | ▲ Bullish | 59.42 | 1.50 |
Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: Bullish, weekly ADX 43.22.
📶 Volume & VWAP
VWAPs are computed from daily bars (typical price × volume), not intraday ticks. Volume has dried up to under 60% of normal.
💪 Relative strength
NEPHROPLUS ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.
🧱 Support & resistance
Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.
| Level | Price | Distance | Touches |
|---|---|---|---|
| Resistance | ₹775.62 | +4.3% | 2 |
| Close | ₹743.35 | — | |
| Support | ₹725.00 | −2.5% | 1 |
| Support | ₹663.90 | −10.7% | 5 |
| Support | ₹609.90 | −17.9% | 6 |
| Support | ₹517.85 | −30.3% | 3 |
52-week range: ₹446.00 – ₹781.50 (-4.88% from the high).
🌀 Fibonacci
Measuring the up-swing from ₹489.85 (2026-03-23) to ₹781.50 (2026-09-11). Price has retraced 13.1% of it.
| Ratio | Price | Distance | |
|---|---|---|---|
| 23.6% retracement | ₹712.67 | -4.1% | nearest |
| 38.2% retracement | ₹670.09 | -9.9% | S/R confluence |
| 50.0% retracement | ₹635.67 | -14.5% | |
| 61.8% retracement | ₹601.26 | -19.1% | |
| 78.6% retracement | ₹552.26 | -25.7% | |
| 127.2% extension | ₹860.83 | +15.8% | |
| 161.8% extension | ₹961.74 | +29.4% | |
| 200.0% extension | ₹1,073.15 | +44.4% |
🕯️ Candlesticks (last 5 sessions)
Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.
↗️ Divergences
No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.
📐 Chart pattern
- Cup and Handle dailyforming
✅ Screens NEPHROPLUS passes today
| Stock | Close | Chg | Score | Trend regime | RS rating (1-99) |
|---|---|---|---|---|---|
| GPTHEALTHGPT Healthcare Limited | ₹166.21 | +1.59% | 93 | Strong Uptrend | 73.00 |
| METROPOLISMetropolis Healthcare Limited | ₹597.45 | +1.90% | 86 | Uptrend | 75.00 |
| MEDANTAGlobal Health Limited | ₹1,499 | +5.29% | 81 | Uptrend | 78.00 |
| YATHARTHYatharth Hospital & Trauma Care Services Limited | ₹1,140 | +6.26% | 81 | Strong Uptrend | 91.00 |
| APOLLOHOSPApollo Hospitals Enterprise Limited | ₹8,944 | +2.01% | 80 | Range | 72.00 |
| BIBilcare | ₹107.62 | +5.00% | 78 | Strong Uptrend | — |
| ARTEMISMEDArtemis Medicare Services Limited | ₹338.50 | +2.31% | 76 | Strong Uptrend | 86.00 |
| KOVAIKovai Medical | ₹6,226 | +1.87% | 76 | Strong Uptrend | — |
| MAXHEALTHMax Healthcare Institute Limited | ₹1,049 | +1.19% | 74 | Range | 50.00 |
| NHNarayana Hrudayalaya Ltd. | ₹1,928 | +3.21% | 74 | Range | 61.00 |
⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.
